• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动物模型中放射性标记嘧啶碱基和嘧啶核苷的肿瘤摄取——VIII. N-[2-(羟基乙氧基)甲基]-5-[³H]甲基尿嘧啶的合成及组织分布

Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--VIII. Synthesis and tissue distribution of N-[2-(hydroxyethoxy) methyl]-5-[3H]methyluracil.

作者信息

Lee Y W, Iwashina T, Gati W P, Knaus E E, Wiebe L I

出版信息

Int J Appl Radiat Isot. 1985 May;36(5):395-8. doi: 10.1016/0020-708x(85)90281-9.

DOI:10.1016/0020-708x(85)90281-9
PMID:4018900
Abstract

The tritium-labelled acyclonucleoside, N-[2-(hydroxyethoxy)methyl]-5-[3H]methyluracil (3H-3), was synthesized for evaluation as a tumor diagnostic agent. 5-[3H]-Methyluracil, 3H-1, was converted to the 2,4-bis-trimethylsilyl intermediate which was coupled with 2-acetoxyethoxymethyl bromide to afford 1-[(2-acetoxyethoxy)methyl-5-[3H]methyluracil (3H-2). Treatment of 3H-2 with sodium methoxide in methanol afforded 3H-3 (specific activity 188 MBq mmol-1. The tissue distribution of 3H-3 was examined in male BDF1 mice bearing Lewis Lung (LL) carcinomas. Long bone exhibited the highest tumor: tissue ratios. The kidney contained the highest radioactivity level relative to the tumor. This suggested a major urinary route of excretion. The major radioactive blood component (89.21%) was found to have a biological half-life of 0.19 min. The title compound is unsuitable for use as a diagnostic agent for LL carcinoma because of low tumor uptake and rapid urinary elimination of injected radioactivity from the body.

摘要

合成了氚标记的无环核苷N-[2-(羟乙氧基)甲基]-5-[³H]甲基尿嘧啶(³H-3),以评估其作为肿瘤诊断剂的性能。5-[³H]甲基尿嘧啶(³H-1)转化为2,4-双三甲基硅烷基中间体,该中间体与2-乙酰氧基乙氧基甲基溴偶联,得到1-[(2-乙酰氧基乙氧基)甲基]-5-[³H]甲基尿嘧啶(³H-2)。在甲醇中用甲醇钠处理³H-2得到³H-3(比活度为188 MBq mmol⁻¹)。在携带Lewis肺癌(LL)的雄性BDF1小鼠中研究了³H-3的组织分布。长骨显示出最高的肿瘤与组织比值。相对于肿瘤,肾脏中的放射性水平最高。这表明主要的排泄途径是通过尿液。发现主要的放射性血液成分(89.21%)的生物半衰期为0.19分钟。由于肿瘤摄取率低且注入体内的放射性从体内通过尿液快速消除,标题化合物不适合用作LL癌的诊断剂。

相似文献

1
Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--VIII. Synthesis and tissue distribution of N-[2-(hydroxyethoxy) methyl]-5-[3H]methyluracil.动物模型中放射性标记嘧啶碱基和嘧啶核苷的肿瘤摄取——VIII. N-[2-(羟基乙氧基)甲基]-5-[³H]甲基尿嘧啶的合成及组织分布
Int J Appl Radiat Isot. 1985 May;36(5):395-8. doi: 10.1016/0020-708x(85)90281-9.
2
Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models: VII. [2-14C]-5-ethyl-1-(2'-deoxy-beta-D-ribofuranosyl)uracil.
Int J Appl Radiat Isot. 1984 Nov;35(11):1063-6. doi: 10.1016/0020-708x(84)90011-5.
3
Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--V. 6-[36Cl]chlorouracil, 6-[82Br]bromouracil and 6-[123I]iodouracil.动物模型中放射性标记嘧啶碱基和嘧啶核苷的肿瘤摄取——V. 6-[36Cl]氯尿嘧啶、6-[82Br]溴尿嘧啶和6-[123I]碘尿嘧啶
Int J Nucl Med Biol. 1984;11(3-4):262-6. doi: 10.1016/0047-0740(84)90010-x.
4
Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models: VI. 1-(3'-[36Cl]-chloro-, 1-(3'-[82Br]-bromo- and 1-(3'-[123I]-Iodo-3'-deoxy-beta-D-arabinofuranosyl)uracil.放射性标记嘧啶碱基和嘧啶核苷在动物模型中的肿瘤摄取:VI. 1-(3'-[36Cl]-氯代、1-(3'-[82Br]-溴代和1-(3'-[123I]-碘代-3'-脱氧-β-D-阿拉伯呋喃糖基)尿嘧啶。
Int J Appl Radiat Isot. 1984 Nov;35(11):1057-61. doi: 10.1016/0020-708x(84)90010-3.
5
Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models. IX. Radiolabelled 1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)uracil and 1-(2'-chloro-2'-deoxy-beta-D-ribofuranosyl)uracil.
Br J Radiol. 1986 Mar;59(699):263-70. doi: 10.1259/0007-1285-59-699-263.
6
Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--I. 6-[3H]-5-fluorouracil.动物模型中放射性标记嘧啶碱基和嘧啶核苷的肿瘤摄取——I. 6-[³H]-5-氟尿嘧啶
Int J Nucl Med Biol. 1979;6(2):97-101. doi: 10.1016/0047-0740(79)90003-2.
7
Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--II. 6-[3H]-5-fluoro-2'-deoxyuridine.动物模型中放射性标记嘧啶碱基和嘧啶核苷的肿瘤摄取——II. 6-[³H]-5-氟-2'-脱氧尿苷
Int J Nucl Med Biol. 1979;6(2):103-7. doi: 10.1016/0047-0740(79)90004-4.
8
Pyrimidine acyclic nucleosides, 1-[(2-Hydroxyethoxy)methyl]pyrimidines as candidate antivirals.嘧啶无环核苷,1-[(2-羟乙氧基)甲基]嘧啶作为潜在的抗病毒药物。
J Med Chem. 1981 Jun;24(6):753-6. doi: 10.1021/jm00138a022.
9
Synthesis, cytotoxicity, and antiviral activity of certain 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine nucleosides related to toyocamycin and sangivamycin.某些与丰加霉素和桑吉瓦霉素相关的7-[(2-羟基乙氧基)甲基]吡咯并[2,3-d]嘧啶核苷的合成、细胞毒性及抗病毒活性
J Med Chem. 1989 Jul;32(7):1420-5. doi: 10.1021/jm00127a003.
10
Synthesis and antiviral activity of certain 4-substituted and 2,4-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines.某些4-取代和2,4-二取代的7-[(2-羟基乙氧基)甲基]吡咯并[2,3-d]嘧啶的合成及抗病毒活性
J Med Chem. 1988 Aug;31(8):1501-6. doi: 10.1021/jm00403a005.